The ICI offers full services regarding the preparation of the file to be submitted for Marketing Authorization of a generic drug in Greece or other EU countries. These services include protocol development, study approval by the pertinent Authorities, the clinical phase, the analytical phase, the statistical evaluation of the results and the final report. The operations are implemented in accordance with EU standards and the procedures of GCP (Good Clinical Practice), GLP (Good Laboratory Practice) and GMP (Good Manufacturing Practice).
The hospitalization of the volunteers during bioequivalence trials will be held in the Military Hospital of the Greek Army, by decision of Φ.900/2/186291
Institute for Clinical Investigation
|6, Poseidonos Av. Athens 17674 Greece|
|tel: 210 64 01 112|